Northern Trust’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Sell |
24,739
-21,287
| -46% | -$170K | ﹤0.01% | 3939 |
|
|
2025
Q1 | $449K | Buy |
46,026
+15,326
| +50% | +$150K | ﹤0.01% | 3619 |
|
|
2024
Q4 | $388K | Buy |
30,700
+387
| +1% | +$4.89K | ﹤0.01% | 3749 |
|
|
2024
Q3 | $487K | Sell |
30,313
-4,082
| -12% | -$65.6K | ﹤0.01% | 3585 |
|
|
2024
Q2 | $839K | Sell |
34,395
-2,662
| -7% | -$65K | ﹤0.01% | 3318 |
|
|
2024
Q1 | $2.66M | Sell |
37,057
-1,066
| -3% | -$76.6K | ﹤0.01% | 2818 |
|
|
2023
Q4 | $7.58M | Buy |
38,123
+911
| +2% | +$181K | ﹤0.01% | 2250 |
|
|
2023
Q3 | $4.95M | Buy |
37,212
+1,268
| +4% | +$169K | ﹤0.01% | 2454 |
|
|
2023
Q2 | $5.38M | Buy |
35,944
+122
| +0.3% | +$18.3K | ﹤0.01% | 2464 |
|
|
2023
Q1 | $5.26M | Buy |
35,822
+4,423
| +14% | +$649K | ﹤0.01% | 2442 |
|
|
2022
Q4 | $4.97M | Buy |
31,399
+337
| +1% | +$53.4K | ﹤0.01% | 2492 |
|
|
2022
Q3 | $5.98M | Buy |
31,062
+378
| +1% | +$72.8K | ﹤0.01% | 2354 |
|
|
2022
Q2 | $4.48M | Buy |
30,684
+4,180
| +16% | +$610K | ﹤0.01% | 2589 |
|
|
2022
Q1 | $4.66M | Sell |
26,504
-333
| -1% | -$58.6K | ﹤0.01% | 2618 |
|
|
2021
Q4 | $7.89M | Sell |
26,837
-313
| -1% | -$92K | ﹤0.01% | 2406 |
|
|
2021
Q3 | $6.75M | Buy |
27,150
+3,938
| +17% | +$978K | ﹤0.01% | 2546 |
|
|
2021
Q2 | $5.9M | Buy |
23,212
+6,159
| +36% | +$1.57M | ﹤0.01% | 2741 |
|
|
2021
Q1 | $3.03M | Sell |
17,053
-1,796
| -10% | -$319K | ﹤0.01% | 3033 |
|
|
2020
Q4 | $2.98M | Buy |
18,849
+293
| +2% | +$46.3K | ﹤0.01% | 2978 |
|
|
2020
Q3 | $4.78M | Sell |
18,556
-78
| -0.4% | -$20.1K | ﹤0.01% | 2559 |
|
|
2020
Q2 | $4.33M | Buy |
18,634
+14,495
| +350% | +$3.37M | ﹤0.01% | 2606 |
|
|
2020
Q1 | $705K | Buy |
4,139
+2,282
| +123% | +$389K | ﹤0.01% | 3351 |
|
|
2019
Q4 | $410K | Buy |
+1,857
| New | +$410K | ﹤0.01% | 3600 |
|